| 125.79 -9.26 (-6.86%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 180.31 |
1-year : | 202.97 |
| Resists | First : | 154.38 |
Second : | 173.77 |
| Pivot price | 137.8 |
|||
| Supports | First : | 123 |
Second : | 102.33 |
| MAs | MA(5) : | 136.47 |
MA(20) : | 137.43 |
| MA(100) : | 181.13 |
MA(250) : | 186.86 |
|
| MACD | MACD : | -4.8 |
Signal : | -5.1 |
| %K %D | K(14,3) : | 30.2 |
D(3) : | 43.9 |
| RSI | RSI(14): 34.7 |
|||
| 52-week | High : | 291.98 | Low : | 123 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ INSP ] has closed below the lower bollinger band by 6.0%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ INSP ] is to continue within current trading range. It is unclear right now based on current values. 53.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 135.26 - 136.03 | 136.03 - 136.86 |
| Low: | 120.99 - 121.78 | 121.78 - 122.65 |
| Close: | 124.27 - 125.67 | 125.67 - 127.2 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Fri, 26 Jul 2024
Vanguard Group Inc. Has $621.26 Million Stake in Inspire Medical Systems, Inc. (NYSE:INSP) - Defense World
Fri, 26 Jul 2024
Comparing Inspire Medical Systems (NYSE:INSP) and BrainsWay (NASDAQ:BWAY) - Defense World
Wed, 24 Jul 2024
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Sold by State Board of Administration of Florida Retirement System - MarketBeat
Tue, 23 Jul 2024
Inspire Medical Systems (NYSE:INSP) Trading Down 4.1% - MarketBeat
Tue, 23 Jul 2024
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France - GlobeNewswire
Tue, 23 Jul 2024
Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 108.4 (%) |
| Shares Short | 1,620 (K) |
| Shares Short P.Month | 1,960 (K) |
| EPS | -0.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.85 |
| Profit Margin | -2.4 % |
| Operating Margin | -9.3 % |
| Return on Assets (ttm) | -3.6 % |
| Return on Equity (ttm) | -2.9 % |
| Qtrly Rev. Growth | 28.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 22.24 |
| EBITDA (p.s.) | -1.11 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 35 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -237.34 |
| PEG Ratio | 13.3 |
| Price to Book value | 6.33 |
| Price to Sales | 5.65 |
| Price to Cash Flow | 107.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|